1. Home
  2. NAC vs OGN Comparison

NAC vs OGN Comparison

Compare NAC & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen California Quality Municipal Income Fund

NAC

Nuveen California Quality Municipal Income Fund

HOLD

Current Price

$11.83

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$7.18

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAC
OGN
Founded
1998
1923
Country
France
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NAC
OGN
Price
$11.83
$7.18
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
$14.10
AVG Volume (30 Days)
307.3K
4.6M
Earning Date
01-01-0001
02-12-2026
Dividend Yield
4.33%
1.12%
EPS Growth
N/A
N/A
EPS
N/A
1.91
Revenue
N/A
$6,301,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$3.73
Revenue Growth
N/A
N/A
52 Week Low
$9.32
$6.18
52 Week High
$11.21
$17.23

Technical Indicators

Market Signals
Indicator
NAC
OGN
Relative Strength Index (RSI) 50.90 48.28
Support Level $11.73 $7.01
Resistance Level $11.79 $7.21
Average True Range (ATR) 0.08 0.21
MACD 0.00 0.05
Stochastic Oscillator 46.15 57.43

Price Performance

Historical Comparison
NAC
OGN

About NAC Nuveen California Quality Municipal Income Fund

Nuveen California Quality Municipal Income Fund is a diversified closed-end management investment company. Its objective is to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal and California state income taxes. It invests majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: